Intravitreal bevacizumab associated with photodynamic therapy in a case of polypoidal choroidal vasculopathy associated with choroidal nevus: A case report.
Medicine (Baltimore)
; 96(52): e9400, 2017 Dec.
Article
in En
| MEDLINE
| ID: mdl-29384917
ABSTRACT
RATIONALE Report the clinical findings and management of a case of polypoidal choroidal vasculopathy associated with choroidal nevus which received combination therapy. PATIENT CONCERNS Decreased visual acuity in a woman with polypoidal choroidal vasculopathy and choroidal nevus. DIAGNOSES Polypoidal choroidal vasculopathy and choroidal nevus. INTERVENTIONS:
The initial visual acuity was 0.5. After the first treatment with photodynamic therapy, exudation and bleeding appeared around the lesion. After this, the patient received 3 doses of intravitreal bevacizumab.OUTCOMES:
After treatment with combination therapy, visual acuity, clinical and imaging findings improved, with no recurrence of exudation and bleeding. LESSONS Intravitreal bevacizumab as an adjunctive treatment after photodynamic therapy is a good option for patients with polypoidal choroidal vasculopathy associated with choroidal nevus.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Photochemotherapy
/
Choroid Neoplasms
/
Choroidal Neovascularization
/
Angiogenesis Inhibitors
/
Bevacizumab
/
Nevus
Type of study:
Risk_factors_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Medicine (Baltimore)
Year:
2017
Document type:
Article
Affiliation country: